Back to search

Article

Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases

2020-06-21

Abstract excerpt

Three patients with severe life-threatening COVID-19 who failed to achieve substantial improvement on tocilizumab, received pulse therapy with corticosteroids (methylprednisolone, 1000 mg/day IV for three consecutive days) and intravenous immunoglobulin (20 g/day IV). This was associated with a prompt resolution of respiratory failure, elimination of cytokine release syndrome, and reversal of pulmonary CT changes....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be20233f-12e7-5337-b457-15bd1af8a3c9
DOI
10.20944/preprints202006.0260.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical CasesDOI 10.20944/preprints202006.0260.v1
The efficacy of combination therapies including antiviral drugs, methylprednisolone and daily proning in 20 patients with COVID-19 requiring invasive mechanical ventilation—Case series in a single critical care center in Osaka, JapanSemantic proximity
Timely Administration of Tocilizumab Improves Survival of Hospitalized COVID-19 PatientsSemantic proximity
Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19Semantic proximity
Safety Comparison of Conventional Versus Extended Infusion of Pulse Methylprednisolone in Multiple Sclerosis Exacerbation Retrospective StudySemantic proximity
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in Covid19 Patients: Report of a Structured Multidisciplinary ConsensusSemantic proximity
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirementSemantic proximity
COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe casesSemantic proximity
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trialSemantic proximity
Select a neighboring publication to make it the new centre.